Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)

por Schattenberg, Jörn M., Bergheim, Ina
Publicado 2019

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers

por Schattenberg, Jörn M., Ekstedt, Mattias
Publicado 2019

Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches

por Armandi, Angelo, Schattenberg, Jörn M.
Publicado 2021

Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?

por Schattenberg, Jörn M., Emrich, Tilman
Publicado 2022

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling

por Schattenberg, Jörn M., Czaja, Mark J.
Publicado 2014

Liver injury in COVID-19: The current evidence

por Alqahtani, Saleh A, Schattenberg, Jörn M
Publicado 2020

NAFLD in the Elderly

por Alqahtani, Saleh A, Schattenberg, Jörn M
Publicado 2021

The unmet need of personalized HCC screening—Lessons learned from the Swedish nationwide registries

por Gairing, Simon Johannes, Schattenberg, Jörn M.
Publicado 2022

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?

por Noureddin, Nabil, Schattenberg, Jörn M., Alkhouri, Naim, Noureddin, Mazen
Publicado 2020

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany

por Labenz, Christian, Kostev, Karel, Kaps, Leonard, Galle, Peter R., Schattenberg, Jörn M.
Publicado 2020

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany

por Labenz, Christian, Kostev, Karel, Armandi, Angelo, Galle, Peter R., Schattenberg, Jörn M.
Publicado 2021

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)

por Nier, Anika, Huber, Yvonne, Labenz, Christian, Michel, Maurice, Bergheim, Ina, Schattenberg, Jörn M.
Publicado 2020

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease

por van Dijk, Anne‐Marieke, Schattenberg, Jörn M., Holleboom, Adriaan G., Tushuizen, Maarten E.
Publicado 2021

Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders

por Gairing, Simon Johannes, Galle, Peter Robert, Schattenberg, Jörn M., Kostev, Karel, Labenz, Christian
Publicado 2021

Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany

por Tilch, Marie-Kristin, Galle, Peter R., Schattenberg, Jörn M., Kostev, Karel, Labenz, Christian
Publicado 2021

The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs

por Cook, Nigel, Geier, Andreas, Schmid, Andreas, Hirschfield, Gideon, Kautz, Achim, Schattenberg, Jörn M., Balp, Maria-Magdalena
Publicado 2019

Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis

por Cook, Nigel, Geier, Andreas, Schmid, Andreas, Hirschfield, Gideon, Kautz, Achim, Schattenberg, Jörn M., Balp, Maria-Magdalena
Publicado 2020

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression

por Labenz, Christian, Huber, Yvonne, Michel, Maurice, Nagel, Michael, Galle, Peter R., Kostev, Karel, Schattenberg, Jörn M.
Publicado 2020

Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib study

por Lawitz, Eric J., Reiberger, Thomas, Schattenberg, Jörn M., Schoelch, Corinna, Coxson, Harvey O., Wong, Diane, Ertle, Judith
Publicado 2023

Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters – an animal model of life style intervention in NAFLD

por Gehrke, Nadine, Biedenbach, Jana, Huber, Yvonne, Straub, Beate K., Galle, Peter R., Simon, Perikles, Schattenberg, Jörn M.
Publicado 2019